ZEMCELPRO is indicated as stem-cell medicine used to treat adults with hematological malignancies (blood cell cancers) who need an allogeneic hematopoietic stem cell transplantation (allo-HSCT) and for whom no other type of suitable donor cells is available. The information on this website is based on the Production Information

This page provides access to the approved Product Information for ZEMCELPRO®, including Summary of Product Characteristics (SmPC), Labelling and Package Leaflet.

For the latest approved Product Information and additional regulatory documents, healthcare professionals may also consult the EMA website.

Healthcare professionals should consult the prescribing information applicable in their country before prescribing, dispensing, or administering ZEMCELPRO®.

First published: 05-SEP-2025

Last updated: 18-FEB-2026